Breaking News Instant updates and real-time market news.

TSRO

Tesaro

$124.31

-2.99 (-2.35%)

, CLVS

Clovis

$75.60

-1.69 (-2.19%)

07:19
08/09/17
08/09
07:19
08/09/17
07:19

Tesaro Zejula off to 'strong initial launch, says Leerink

Leerink analyst Seamus Fernandez notes that Tesaro (TSRO) reported Q2 earnings with $25.9M in Zejula sales during its first quarter on the market following approval for second-line or greater ovarian cancer maintenance, more than doubling consensus estimates. With more than 1,500 new patient starts in the quarter, Zejula is off to a "strong" initial launch, he adds. However, the analyst believes it will likely soon face competition from Clovis' (CLVS) Rubraca and AstraZeneca's (AZN) Lynparza following their likely approvals in this setting. Fernandez reiterates a Market Perform rating and $143 price target on Tesaro's shares.

TSRO

Tesaro

$124.31

-2.99 (-2.35%)

CLVS

Clovis

$75.60

-1.69 (-2.19%)

AZN

AstraZeneca

$29.30

-0.32 (-1.08%)

TSRO Tesaro
$124.31

-2.99 (-2.35%)

08/08/17
MSCO
08/08/17
NO CHANGE
MSCO
Morgan Stanley buyers of Clovis and Tesaro into Lynparza label decision
Morgan Stanley analyst Andrew Berens would be a buyer of Clovis (CLVS) and Tesaro (TSRO) ahead of the broad label decision for AstraZeneca's (AZN) Lynparza in 2L maintenance setting expected in Q3. Berens sees minimal fundamental impact to both stocks, even if AstraZeneca receives a broad label. He thinks a broad label will be limited to BRCA patients, or the FDA will place caveats as having inferior data outside of BRCA, and both stocks will benefit as an overhang is lifted.
08/01/17
JANY
08/01/17
NO CHANGE
JANY
Neutral
Robust launch for Idhifa already reflected in Agios shares, says Janney Capital
Janney Capital analyst Debjit Chattopadhyay said he anticipates rapid adoption of Idhifa and expects a robust commercial launch led by Agios' (AGIO) partner Celgene (CELG), but he also believes this is reflected in the stock. The wholesale acquisition cost of $24,872 is significantly higher than Tesaro's (TSRO) Zejula and Clovis' (CLVS) Rubraca, noted Chattopadhyay, who added that the higher WAC and potentially longer median duration of therapy represents upside to his current estimates. He keeps a Neutral rating on Agios, which will receive a low double digit to mid teens royalty for Idhifa.
07/27/17
JANY
07/27/17
NO CHANGE
Target $107
JANY
Buy
PARP deals may make Clovis more attractive buyout candidate, says Janney
The partnerships announced today between AstraZeneca (AZN) and Merck (MRK) as well as Tesaro (TSRO) and Takeda highlight pharma's willingness to expand on PARP's, Janney analyst Debjit Chattopadhyay tells investors in a research note. Clovis' (CLVS) Rubraca is now the only unencumbered PARP and is "far cheaper" on a relative valuation basis than peer Tesaro, the analyst adds. He believes Clovis could now become a more compelling takeover candidate. Chattopadhyay has a Buy rating on the shares with a $107 price target. The stock in midday trading is up 7%, or $5.90, to $93.33.
07/27/17
FBCO
07/27/17
NO CHANGE
FBCO
Merck unlikely to buy PARP company after Astra deal, says Credit Suisse
Credit Suisse analyst Alethia Young believes Merck (MRK) is unlikely to acquire a PARP inhibitor company like Tesaro (TSRO) or Clovis (CLVS) after inking an immuno-oncology deal with AstraZeneca (AZN).
CLVS Clovis
$75.60

-1.69 (-2.19%)

07/31/17
JPMS
07/31/17
NO CHANGE
JPMS
Clovis takeover thesis not off the table, says JPMorgan
JPMorgan said the Clovis (CLVS) and Bristol-Myers (BMY) collaboration does not impact the takeover thesis of Clovis. Analyst Cory Kasimov said the the no-strings-attached clinical collaboration has no financial terms aside from provision of study drug and sharing of trial costs in some instances and Bristol does not have first rights of refusal if an interested party did approach Clovis.
07/31/17
LEER
07/31/17
NO CHANGE
LEER
Outperform
Clovis weakness unwarranted after Bristol-Myers pact, says Leerink
Leerink analyst Michael Schmidt thinks today's weakness in Clovis (CLVS) is unwarranted following the company's clinical collaboration agreement with Bristol-Myers (BMY) and presents a buying opportunity. This deal does not preclude a future acquisition of the company, but it does increase the competitiveness and value of Rubraca, argues Schmidt, who reiterates his Outperform rating on Clovis shares.
AZN AstraZeneca
$29.30

-0.32 (-1.08%)

08/09/17
PIPR
08/09/17
NO CHANGE
PIPR
Overweight
AstraZeneca recent selloff a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Richard Purkiss believes the recent negative MYSTIC update from AstraZeneca has created a long-term buying opportunity. 2017 marks an earnings trough year for the company, and the shares now trade at discounted valuation, Purkiss tells investors in a research note. He reiterates an Overweight rating on the shares with a GBP 51 price target.
08/01/17
PART
08/01/17
UPGRADE
PART
Hold
AstraZeneca upgraded to Hold from Sell at Pareto
07/28/17
07/28/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Starbucks (SBUX) was downgraded to Neutral from Buy at Guggenheim and to Hold from Buy at Stifel. 2. Spirit Airlines (SAVE) was downgraded to Neutral from Buy at Buckingham and BofA/Merrill and to In-Line from Outperform at Imperial Capital. 3. Flowers Foods (FLO) downgraded to Hold from Buy at Jefferies with analyst Akshay Jagdale saying his positive thesis on bread industry pricing becoming more rational has not played out. 4. AstraZeneca (AZN) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Vincent Meunier saying shares look fairly valued as he removed MYSTIC from his models. 5. U.S. Steel (X) downgraded to Sell from Neutral at Citi with analyst Alexander Hacking saying he sees downside risk to U.S. flat rolled prices for the remainder of 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

XLE

Energy Select Sector SPDR

$62.36

0.35 (0.56%)

, XLU

Utilities SPDR

$54.48

0.3 (0.55%)

12:06
08/18/17
08/18
12:06
08/18/17
12:06
Technical Analysis
Technical View: S&P 500 edges above flatline, mid-session update »

The S&P 500 (SPX) was…

XLE

Energy Select Sector SPDR

$62.36

0.35 (0.56%)

XLU

Utilities SPDR

$54.48

0.3 (0.55%)

XLF

Financial Select Sector

$24.72

0.105 (0.43%)

XLK

Technology Select Sector SPDR

$57.33

0.2 (0.35%)

IYR

DJ US Real Estate Index Fund

$79.07

-0.7 (-0.88%)

XLP

Consumer Staples Sector SPDR

$55.25

-0.105 (-0.19%)

XLY

Consumer Discretionary Sector SPDR

$88.62

-0.07 (-0.08%)

SPY

SPDR S&P 500 ETF Trust

$243.52

0.43 (0.18%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$910.98

-15.98 (-1.72%)

, GOOGL

Alphabet Class A

$927.66

-16.61 (-1.76%)

12:04
08/18/17
08/18
12:04
08/18/17
12:04
Hot Stocks
Google launches new machine learning tool to track hate news »

In a blog post…

GOOG

Alphabet

$910.98

-15.98 (-1.72%)

GOOGL

Alphabet Class A

$927.66

-16.61 (-1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 24

    Aug

FMAO

Farmers & Merchants

$55.58

-0.17 (-0.30%)

12:00
08/18/17
08/18
12:00
08/18/17
12:00
Hot Stocks
Farmers & Merchants board declares two-for-one stock split »

Farmers & Merchants…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$117.19

-6.7905 (-5.48%)

, CPN

Calpine

$14.83

1.33 (9.85%)

12:00
08/18/17
08/18
12:00
08/18/17
12:00
General news
On The Fly: Top stock stories at midday »

Stocks opened in negative…

DE

Deere

$117.19

-6.7905 (-5.48%)

CPN

Calpine

$14.83

1.33 (9.85%)

GPS

Gap

$22.43

-0.255 (-1.12%)

ROST

Ross Stores

$53.33

-1.04 (-1.91%)

AMAT

Applied Materials

$43.12

-1.34 (-3.01%)

THC

Tenet

$14.04

1.385 (10.95%)

INFY

Infosys

$14.71

-1.22 (-7.66%)

FL

Foot Locker

$34.97

-12.73 (-26.69%)

FINL

Finish Line

$11.99

-0.17 (-1.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 18

    Aug

  • 23

    Aug

  • 06

    Sep

  • 06

    Sep

  • 22

    Nov

BC

Brunswick

$50.33

-0.995 (-1.94%)

12:00
08/18/17
08/18
12:00
08/18/17
12:00
Options
Call buyers in Brunswick as shares fall »

Call buyers in Brunswick…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

FL

Foot Locker

$34.98

-12.7201 (-26.67%)

11:59
08/18/17
08/18
11:59
08/18/17
11:59
Downgrade
Foot Locker rating change  »

Foot Locker downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

RDUS

Radius Health

$35.42

-1.01 (-2.77%)

11:58
08/18/17
08/18
11:58
08/18/17
11:58
Hot Stocks
Biotech Growth acquires 60,000 more shares of Radius Health »

Biotech Growth NV…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

CVNA

Carvana

$15.12

-0.06 (-0.40%)

11:54
08/18/17
08/18
11:54
08/18/17
11:54
Hot Stocks
Breaking Hot Stocks news story on Carvana »

Carvana drops 3% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 06

    Sep

  • 12

    Sep

CVNA

Carvana

$15.12

-0.06 (-0.40%)

11:53
08/18/17
08/18
11:53
08/18/17
11:53
Periodicals
Carvana mentioned cautiously by Copperfield Research »

Copperfield Research, in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 06

    Sep

  • 12

    Sep

AMAT

Applied Materials

$43.12

-1.34 (-3.01%)

11:51
08/18/17
08/18
11:51
08/18/17
11:51
Hot Stocks
Applied Materials CEO says technological shifts in industries to drive growth »

The CEO says has a good…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$34.76

-12.94 (-27.13%)

11:50
08/18/17
08/18
11:50
08/18/17
11:50
Recommendations
Foot Locker analyst commentary  »

Foot Locker comp outlook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

11:50
08/18/17
08/18
11:50
08/18/17
11:50
General news
Fed's Kaplan sees GDP growth a little above 2% for 2017 »

Fed's Kaplan sees…

AMZN

Amazon.com

$960.57

-17.61 (-1.80%)

, ATVI

Activision Blizzard

$61.37

-1.52 (-2.42%)

11:49
08/18/17
08/18
11:49
08/18/17
11:49
Periodicals
Twitch acquires video indexing platform Clipmine, TechCrunch reports »

Twitch has acquired video…

AMZN

Amazon.com

$960.57

-17.61 (-1.80%)

ATVI

Activision Blizzard

$61.37

-1.52 (-2.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 23

    Aug

  • 24

    Aug

  • 24

    Aug

  • 05

    Sep

  • 07

    Sep

FL

Foot Locker

$34.82

-12.88 (-27.00%)

11:45
08/18/17
08/18
11:45
08/18/17
11:45
Downgrade
Foot Locker rating change  »

Wells doubts investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

AMAT

Applied Materials

$43.12

-1.34 (-3.01%)

11:42
08/18/17
08/18
11:42
08/18/17
11:42
Hot Stocks
Applied Materials CEO says much less volatility in chip sector »

The Applied Materials CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$34.94

-12.76 (-26.75%)

, NKE

Nike

$55.19

-2.27 (-3.95%)

11:41
08/18/17
08/18
11:41
08/18/17
11:41
Recommendations
Foot Locker, Nike, adidas analyst commentary  »

Foot Locker price target…

FL

Foot Locker

$34.94

-12.76 (-26.75%)

NKE

Nike

$55.19

-2.27 (-3.95%)

ADDYY

adidas

$111.98

-1.52 (-1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 03

    Oct

  • 04

    Oct

NBL

Noble Energy

$23.44

0.415 (1.80%)

11:40
08/18/17
08/18
11:40
08/18/17
11:40
Options
Notable put spread in Noble Energy »

Notable put spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

ABCO

The Advisory Board

$51.05

-0.8 (-1.54%)

11:35
08/18/17
08/18
11:35
08/18/17
11:35
Options
Advisory Board put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTNB

root9B Technologies

$0.60

-0.1665 (-21.72%)

11:30
08/18/17
08/18
11:30
08/18/17
11:30
Hot Stocks
Breaking Hot Stocks news story on root9B Technologies »

root9B Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNGA

Magnegas

$0.49

0.013139 (2.76%)

11:25
08/18/17
08/18
11:25
08/18/17
11:25
Conference/Events
Magnegas to host business news update conference call »

Management provides a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Aug

URBN

Urban Outfitters

$18.94

-0.82 (-4.15%)

11:20
08/18/17
08/18
11:20
08/18/17
11:20
Options
Urban Outfitters Sep 15 puts trade more than 90K »

Urban Outfitters Sep 15…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:20
08/18/17
08/18
11:20
08/18/17
11:20
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

11:19
08/18/17
08/18
11:19
08/18/17
11:19
Periodicals
White House officials expect Steve Bannon to be fired, Axios reports »

White House chief of…

$NSD

NASDAQ Market Internals

11:17
08/18/17
08/18
11:17
08/18/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
08/18/17
08/18
11:16
08/18/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.